Discontinuation report APO-ALENDRONATE
Report ID | 60163 |
Drug Identification Number | 02248728 |
Brand name | APO-ALENDRONATE |
Common or Proper name | ALENDRONATE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | ALENDRONIC ACID |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 BLS |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2020-05-31 |
Actual discontinuation date | |
Remaining supply date | 2020-05-31 |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.